Point your AI agent at freehire and let it find you a job.

Get the CLI →

Miltenyi Biotec

Miltenyi Biotec is a global biotechnology company that provides products and services for biomedical research and cellular therapy. Founded in 1989, it is a leader in cell separation, analysis, and therapy solutions.

Licensed UK sponsor — This employer appears on the GOV.UK register of licensed sponsors for the Skilled Worker and related work routes. The licence belongs to the employer and is not a commitment to sponsor this role.Licensed NL sponsor — This employer appears on the IND public register of recognised sponsors for work and highly skilled migrants. The recognition belongs to the employer and is not a commitment to sponsor this role.H-1B sponsor history — This employer has had H-1B petitions approved by USCIS in the last five fiscal years, per the USCIS H-1B Employer Data Hub. The approval belongs to the employer and is not a commitment to sponsor this role.
Discussion

Company facts

Founded
1989
Headquarters
Germany
CEO
Stefan Miltenyi, Dr. Boris Stoffel

About

The story of Miltenyi Biotec is a journey that began not in a sprawling corporate campus, but from the inventive mind of a physicist. In 1989, Stefan Miltenyi, the company's founder, developed a groundbreaking technology in a humble workshed on the outskirts of Bergisch-Gladbach, Germany. This invention was Magnetic-Activated Cell Sorting, or MACS® Technology, a revolutionary method for separating specific cells from complex biological samples. This deceptively simple yet powerful technique, which used antibodies attached to tiny magnetic beads to isolate target cells, was destined to become a cornerstone of biomedical research. With an initial capital of just 10,000 Deutsche Marks, Stefan Miltenyi founded the company that bears his name, driven by a vision to translate scientific discovery into practical tools for researchers and clinicians. From these modest beginnings, Miltenyi Biotec embarked on a path of remarkable growth, fueled by a commitment to innovation and a deep understanding of the scientific community's needs. The company quickly expanded beyond its German roots, establishing its first U.S. subsidiary in 1992 and steadily opening offices across Europe, Asia, and Australia. What started as a four-person operation has blossomed into a global enterprise with over 5,000 employees worldwide. The product portfolio, which began with the foundational MACS technology, has expanded dramatically to encompass a comprehensive suite of integrated solutions for the entire cell and gene therapy workflow. This includes instruments and reagents for sample preparation, cell separation and analysis, flow cytometry, cell culture, molecular analysis, and clinical applications. Today, Miltenyi Biotec stands as a pivotal player in the advancement of cellular therapy, empowering scientists and physicians to tackle some of the most challenging diseases of our time, including cancer, autoimmune disorders, and neurodegenerative diseases, and making the promise of personalized medicine a tangible reality for patients around the globe.

39 jobs

Tailor your CV for this role?

We couldn't check your fit for this role — add a CV to your profile to see it next time.

A new version of freehire is available